Orthofix International reported $219.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Dexcom USD 1.34B 30M Sep/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
J&J USD 25.4B 89M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
STAAR Surgical USD 83.4M 10.1M Sep/2026
Stryker USD 6.5B 100M Sep/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Veracyte USD 151.75M 1.43M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026